Scientists studied how asbestos exposure alters the genes of malignant pleural mesothelioma. They published their findings in the Journal of Environmental Pathology, Toxicology, and Oncology. This helped to show how the genes of three tumors form. The study helped to deepen our knowledge of mesothelioma’s genetic changes and their connection[…]
Full Archive
Fibroblasts and Mesothelioma
Malignant mesothelioma, a rare and aggressive cancer mainly caused by asbestos exposure, is a cancer of the lining of certain organs including the lungs, abdomen, heart, and testicles. It is very dangerous because it grows and spreads quickly and treatment options are limited. Asbestos is no longer used widely in[…]
Gene Alterations Resulting from Pleural Mesothelioma
Scientists recently studied how asbestos exposure alters the genes of pleural mesothelioma, with the findings being published in the Journal of Environmental Pathology, Toxicology, and Oncology. This allowed scientists to show how the genes of three tumors in patients form. Overall, the study deepened our knowledge of mesothelioma’s genetic changes[…]
Finding Mesothelioma in Situ
Pleural mesothelioma is a rare and aggressive cancer mainly caused by asbestos exposure. It mainly affects the pleura, the thin membrane that surrounds the lungs. Many people do not know their mesothelioma is from asbestos exposure because it can take decades from the time of exposure to be diagnosed with[…]
Surgery and Improved Mesothelioma Survival
Pleural mesothelioma is a rare and aggressive cancer. The cancer with a poor prognosis is mainly caused by asbestos. Surgery is an important part of treating pleural mesothelioma, but the impact of surgery on patients’ survival is unclear and sparking debate. A recent study was presented at the World Conference[…]
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease ((RIOT 4A))
Primary Outcome Measures Document the feasibility of local manufacture of ACT product from drained pleural effusions using the CliniMACS Prodigy® device To demonstrate the safety of intrapleural administration of the locally manufactured ACT product plus Interleukin 2 (IL-2) to study patients Secondary Outcome Measures To document changes in the pleural[…]
Opdivo and Yervoy Before and After Surgery and a New Blood Test are Improving Mesothelioma Treatment
Researchers are reporting promising results for people with mesothelioma who can have surgery. One researcher tested immunotherapy before and after surgery while the other researcher studied a blood test that helps doctors detect mesothelioma earlier than scans. Doctors at several cancer centers, including Johns Hopkins, ran an early clinical trial[…]
Cell Mutations and Peritoneal Mesothelioma
Peritoneal mesothelioma is a hard cancer to treat because it is very aggressive and rare. It is usually found late due to it being rare and having unclear symptoms, making treatment very difficult. Current treatments that can include surgery and chemotherapy have limited success against the cancer. New ways to[…]
New Biomarkers for Diagnosing Mesothelioma
Mesothelioma is a rare cancer linked to asbestos exposure that is dangerous for elderly Americans. It is hard to tell the difference between reactive and cancerous cells. This could be changed though due to a study in the American Journal of Pathology. The study identifies a key biomarker, ACADL, using[…]
Palliative Care for Mesothelioma Symptoms
Palliative care is crucial in improving quality of life for people with life threatening diseases like mesothelioma. Understanding the spectrum of diseases that patients experience is important for providing effective care. Palliative care is a medical specialty that focuses on easing pain and other life limiting symptoms. Palliative care is[…]
